develop
use
vero
cell
cultur
system
cell
use
viral
vaccin
product
anchorag
depend
thu
process
involv
cell
easili
scale
need
anchorag
space
trypsin
led
develop
immort
stabl
cell
line
capabl
growth
suspens
recent
studi
research
succeed
grow
vero
cell
microcarri
prepar
suspens
cultur
cell
rourou
et
al
report
suspens
cultiv
agit
vero
cell
cultur
promot
measl
rabi
viru
product
cell
addit
shen
et
al
show
suspensionadapt
vero
cell
cultiv
without
microcarri
produc
higher
amount
vesicular
stomat
viru
vsv
adher
vero
cell
howev
hurdl
associ
vero
cell
longer
cell
doubl
time
low
cell
viabil
still
remain
address
via
formul
appropri
adapt
process
convent
cell
cultur
produc
viral
vaccin
strain
use
animalderiv
compon
serum
trypsin
lactalbumin
etc
usag
serum
prefer
due
high
cost
lottolot
variat
addit
viral
bacteri
fungal
contamin
bovin
serum
one
major
concern
associ
manufactur
cell
culturebas
vaccin
therefor
optim
cell
cultur
system
without
serum
mandatori
product
viral
vaccin
strain
sever
studi
attempt
develop
serumfre
product
platform
viru
propag
previou
studi
mdck
cell
cultur
serumfre
excel
mdck
produc
higher
amount
influenza
viru
cultur
serumcontain
glasgow
minimum
esssenti
medium
furthermor
vero
cell
cultur
serumfre
medium
also
explor
produc
mani
viral
vaccin
strain
studi
attempt
promot
adapt
vero
cell
shake
suspens
cultur
system
determin
cultur
media
optim
cultur
vero
cell
without
serum
vero
cell
success
adapt
suspens
cultur
system
produc
higher
amount
adenovirus
compar
convent
adhes
cultur
vero
cell
vero
cell
maintain
dulbecco
modifi
eagl
medium
dmem
hyclon
thermo
scientif
waltham
usa
supplement
fetal
bovin
serum
fb
gibco
gaithersburg
md
usa
uml
penicillin
streptomycin
gibco
condit
cell
cultur
modifi
eagl
medium
mem
gibco
contain
fb
uml
penicillin
streptomycin
adenoviru
type
green
fluoresc
protein
gfp
kindli
provid
prof
jaehwan
nam
cathol
univers
korea
viru
propag
vero
cell
dmem
contain
fb
optipro
sfm
vpsfm
purchas
gibco
serumfre
ultralow
protein
media
contain
protein
peptid
compon
anim
human
origin
optmem
reducedserum
medium
gibco
improv
mem
allow
reduct
fb
supplement
ultracultur
medium
lonza
vervier
belgium
serumfre
medium
design
cultiv
mammalian
cell
type
supplement
recombin
human
insulin
bovin
transferrin
purifi
mixtur
bovin
serum
protein
includ
albumin
hyclon
logan
ut
usa
proteinfre
medium
design
increas
process
yield
manufactur
viral
vaccin
contain
animalderiv
compon
stepwis
reduct
percentag
fb
perform
adapt
serumfre
cultur
condit
adapt
cell
attempt
five
media
optipro
ultracultur
optimem
vpsfm
cell
cultur
condit
cell
seed
cultur
dish
concentr
cellsdish
hour
cultur
condit
total
cell
number
determin
use
hemocytomet
marienfeld
germani
along
trypan
blue
stain
follow
subcultur
cellsdish
stepwis
reduct
percentag
convent
medium
morpholog
cell
cultur
media
evalu
base
cell
number
shape
use
invert
phasecontrast
microscop
dmill
leica
microsystem
wetzlar
germani
magnif
vero
cell
grown
erlenmey
flask
spl
life
scienc
pocheon
korea
condit
use
orbit
shaker
maxq
plu
thermo
scienhttp
wwwecevrorg
http
tific
adhes
cell
cultur
erlenmey
flask
day
orbit
shaker
condit
viabl
cell
evalu
use
hemocytomet
along
trypan
blue
stain
next
adhes
cell
ad
shake
suspens
cultur
densiti
cellsm
viabl
cell
suspens
cultiv
continu
cultur
viabil
monitor
day
trypan
blue
stain
viru
contain
gene
gfp
control
cytomegaloviru
promot
viru
propag
perform
vero
cell
follow
titrat
comparison
viru
product
adhes
suspens
cultur
system
two
type
vero
cell
seed
densiti
cellsml
cultur
dish
erlenmey
flask
incub
hour
cell
infect
multipl
infect
day
rel
amount
produc
determin
measur
fluoresc
intens
use
fluoresc
micropl
reader
spectramax
molecular
devic
salzburg
austria
data
express
error
mean
statist
analysi
perform
use
graphpad
prism
ver
graphpad
softwar
san
diego
ca
usa
pvalu
assess
use
unpair
twotail
student
ttest
signific
level
p
investig
whether
vero
cell
could
cultur
serumfre
condit
vpsfm
ultracultur
optiprosfm
optimem
test
term
morpholog
chang
growth
rate
vero
cell
reduc
serum
cultiv
condit
vero
cell
cultur
optipro
vpsfm
show
morpholog
similar
vero
cell
cultur
convent
cultur
media
dmem
contain
fb
fig
howev
vero
cell
cultur
ultracultur
optimem
show
abnorm
morpholog
cell
aggreg
observ
convent
cultur
condit
serum
concentr
reduc
vero
cell
cultur
optipro
show
decreas
growth
rate
initi
cultur
stage
fb
growth
rate
increas
higher
compar
convent
cultur
condit
dmem
fb
day
cultur
fb
fig
howev
growth
rate
vero
cell
cultur
vpsfm
media
lower
vero
cell
cultur
convent
cultur
condit
collect
vero
cell
cultur
without
morpholog
chang
decreas
growth
rate
use
optipro
serumfre
media
test
whether
optim
serumfre
condit
vero
cell
appli
anoth
vaccin
strainproduc
cell
line
control
cell
ie
cell
cell
cultur
optipro
vpsfm
show
abnorm
cellular
morpholog
shorten
cell
compar
cultur
convent
cultur
media
mem
contain
fb
fig
cell
cultur
optimem
optipro
vpsfm
ultracultur
show
abnorm
morpholog
fig
growth
rate
cell
vpsfm
optipro
serumfre
medium
lower
cell
cultur
convent
medium
mem
fb
optimem
ultracultur
medium
howev
cellular
morpholog
chang
cell
cultur
optimem
ultracultur
could
continu
reduc
fb
fig
cell
cultur
vpsfm
optimem
show
similar
growth
rate
compar
cultur
convent
cultur
medium
fig
conclus
optim
cultur
condit
vero
cell
absenc
fb
may
applic
vaccin
strainproduc
cell
cell
tri
cultur
vero
cell
shake
suspens
cultur
system
vero
cell
cultur
shake
cultur
system
ad
addit
vero
cell
adhes
cultur
day
cultur
cell
without
ad
adhes
vero
cell
day
fig
day
shake
suspens
cultur
growth
rate
vero
cell
decreas
addit
vero
cell
cultur
adhes
condit
howev
day
suspens
cultur
follow
addit
vero
cell
growth
rate
slightli
increas
day
suspens
cultur
growth
rate
http
wwwecevrorg
http
vero
cell
continu
increas
subcultur
fig
sinc
vero
cell
adapt
shake
suspens
cultur
system
test
vero
cell
term
abil
viru
gener
use
viru
gener
marker
vero
cell
cultur
adhes
shake
suspens
cultur
show
cytopath
effect
day
infect
fig
suspens
cultur
vero
cell
show
significantli
higher
gfp
intens
higher
adhes
counterpart
indic
vero
cell
cultur
shake
suspens
condit
serv
suitabl
cultur
system
produc
viral
vaccin
strain
effici
compar
convent
cultur
system
vero
cell
fig
studi
show
optipro
use
cultur
vero
cell
without
serum
addit
also
achiev
establish
microcarrierfre
suspens
cultur
system
vero
cell
sinc
suspens
cultur
system
much
less
laborintens
procedur
adhes
cultur
system
sever
studi
attempt
cultur
cell
produc
viral
vaccin
strain
suspens
cultur
system
sever
studi
publish
data
support
propag
rabi
japanes
enceph
virus
suspens
cultur
system
howev
previou
studi
describ
suspens
cultur
requir
microcarri
anchorag
herein
develop
vero
cell
suspens
cultur
system
without
use
microcarri
although
earli
phase
cultur
lower
cell
number
lower
specif
growth
rate
observ
day
total
cell
number
cell
growth
rate
increas
previou
studi
vero
cell
adapt
suspens
growth
show
efficaci
vsv
propag
anoth
studi
demonstr
suspensionadapt
vero
cell
produc
higher
amount
virus
adher
vero
cell
studi
show
vero
cell
cultur
shake
suspens
cultur
system
gener
higher
amount
adenoviru
vero
cell
cultur
adhes
plate
optipro
serumfre
medium
free
animalderiv
compon
low
concentr
nonanim
deriv
protein
optipro
design
sever
kidneyderiv
cell
line
includ
mdbk
mdck
vero
cell
sever
studi
report
applic
optipro
cell
culturebas
viru
propag
best
knowledg
demonstr
first
time
feasibl
commerci
serumfre
medium
optipro
vaccin
product
use
vero
cell
howev
studi
sever
limit
although
determin
serumfre
condit
media
suitabl
vero
cell
cultur
appli
cultur
media
shake
suspens
cultur
system
growth
rate
vero
cell
viru
product
condit
thu
still
unclear
studi
show
shake
suspens
system
induc
higher
product
vero
cell
verifi
whether
establish
suspens
cultur
system
also
applic
product
virus
verifi
studi
use
variou
viral
vaccin
strain
also
confirm
tumorigen
suspens
cultureadapt
vero
cell
adapt
process
may
chang
characterist
vero
cell
aspect
need
investig
elucid
via
futur
research
conclus
demonstr
vero
cell
suspens
cultur
allow
product
high
yield
viral
vaccin
strain
reduc
product
cost
